frozen cycles following endometrial preparation with estrogen and progesterone compared with tamoxife
Phase 3
- Conditions
- Infertility.Female inf
- Registration Number
- IRCT20110509006420N23
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Frozen embryo transfer candidate
With polycystic ovary syndrome based on the Rotterdam criteria
Exclusion Criteria
Severe male infertility includes cases of azoospermia and sperm from TESE or PESA History of
History of uterine surgery such as hysteroscopic surgery
Body mass index more than 30
Use of coumarin anticoagulants
DVT history
pulmonary edema
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chemical pregnancy. Timepoint: 15 days after embryo transfer. Method of measurement: Blood laboratory kit.;Clinical pregnancy. Timepoint: 3 weeks after positive beta-h Cg. Method of measurement: Observation of fetal heart activity by transvaginal ultrasonography.
- Secondary Outcome Measures
Name Time Method Miscarriage rate. Timepoint: Loss of pregnancy before 20 gestational week. Method of measurement: Absence of fetal heart activity in ultra sound sonography.;Implantation rate. Timepoint: 3 weeks after positive beta-h Cg. Method of measurement: Calculated by the number of gestational sacs observed on ultrasound on the number of embryos transferred.